PEN-866

Tarveda Therapeutics Doses First Patient in Study of Innovative Conjugate PEN-866 for Patients With Solid Tumors
CP Wire
Tue, 04/24/18 - 09:17 am
Tarveda Therapeutics
PEN-866
solid tumors